Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study

We studied the feasibility, safety, tolerability and pharmacokinetics of intracerebroventricular delivery of recombinant human vascular endothelial growth factor in patients with amyotrophic lateral sclerosis. In this phase I study in patients with amyotrophic lateral sclerosis, the study drug was d...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Brain Commun
Glavni autori: Van Damme, Philip, Tilkin, Petra, Mercer, Katarina Jansson, Terryn, Joke, D’Hondt, Ann, Herne, Nina, Tousseyn, Thomas, Claeys, Kristl G, Thal, Dietmar R, Zachrisson, Olof, Almqvist, Per, Nuttin, Bart, Jerling, Markus, Bernadotte, Folke, Haegerstrand, Anders, Robberecht, Wim
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099230/
https://ncbi.nlm.nih.gov/pubmed/33977260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcaa160
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items